Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 5
2003 5
2004 6
2005 10
2006 15
2007 18
2008 19
2009 21
2010 18
2011 24
2012 13
2013 19
2014 17
2015 7
2016 16
2017 11
2018 13
2019 16
2020 20
2021 20
2022 14
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
Atorvastatin calcium plus amlodipine for the treatment of hypertension.
Delgado-Montero A, Zamorano JL. Delgado-Montero A, et al. Expert Opin Pharmacother. 2012 Dec;13(18):2673-85. doi: 10.1517/14656566.2012.742064. Epub 2012 Nov 10. Expert Opin Pharmacother. 2012. PMID: 23140185 Review.
AREAS COVERED: In this article the authors describe the first combined fixed-dose pill of an antihypertensive and a lipid-lowering agent, the single-pill combination of amlodipine besylate and atorvastatin calcium (SPAA). They summarize the pharmacokinetic an …
AREAS COVERED: In this article the authors describe the first combined fixed-dose pill of an antihypertensive and a lipid-lowering agent, th …
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P. Gupta A, et al. Lancet. 2018 Sep 29;392(10153):1127-1137. doi: 10.1016/S0140-6736(18)31776-8. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158072 Free article. Clinical Trial.
FINDINGS: Of 8580 UK-based patients in ASCOT, 3282 (38.3%) died, including 1640 (38.4%) of 4275 assigned to atenolol-based treatment and 1642 (38.1%) of 4305 assigned to amlodipine-based treatment. 1768 of the 4605 patients in the LLA died, including 903 (39.5%) of 2288 as …
FINDINGS: Of 8580 UK-based patients in ASCOT, 3282 (38.3%) died, including 1640 (38.4%) of 4275 assigned to atenolol-based treatment and 164 …
Stenting and medical therapy for atherosclerotic renal-artery stenosis.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators. Cooper CJ, et al. N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18. N Engl J Med. 2014. PMID: 24245566 Free PMC article. Clinical Trial.
A single-pill combination of amlodipine besylate and atorvastatin calcium.
Blank R. Blank R. Drugs Today (Barc). 2006 Mar;42(3):157-75. doi: 10.1358/dot.2006.42.3.953593. Drugs Today (Barc). 2006. PMID: 16628258 Review.
This review describes the clinical profile and rationale for the development of a single-pill formulation of the calcium channel blocker amlodipine besylate, a blood pressure-lowering agent with pleiotropic effects, and atorvastatin calcium, a statin w …
This review describes the clinical profile and rationale for the development of a single-pill formulation of the calcium channel bloc …
Amlodipine/atorvastatin (Caduet).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2004 Jul 5;46(1186):56. Med Lett Drugs Ther. 2004. PMID: 15237282 No abstract available.
Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
Chung M, Calcagni A, Glue P, Bramson C. Chung M, et al. J Clin Pharmacol. 2006 Sep;46(9):1030-7. doi: 10.1177/0091270006291031. J Clin Pharmacol. 2006. PMID: 16920898 Clinical Trial.
The bioequivalence of combination tablets containing amlodipine besylate/atorvastatin calcium with coadministered matching doses of amlodipine besylate and atorvastatin calcium tablets was investigated in randomized, 2-way crossover studi …
The bioequivalence of combination tablets containing amlodipine besylate/atorvastatin calcium with coadministered match …
A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
Blank R, Hobbs FD, Zamorano J, Girerd X. Blank R, et al. Drugs Today (Barc). 2007 Mar;43(3):157-77. doi: 10.1358/dot.2007.43.3.1079878. Drugs Today (Barc). 2007. PMID: 17380213 Review.
This review describes the clinical profile and rationale for the development of a single-pill formulation of the calcium channel blocker amlodipine besylate, a blood-pressure--lowering agent, and atorvastatin calcium, a statin with lipid-lowering antia …
This review describes the clinical profile and rationale for the development of a single-pill formulation of the calcium channel bloc …
Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
Curran MP. Curran MP. Drugs. 2010;70(2):191-213. doi: 10.2165/11204420-000000000-00000. Drugs. 2010. PMID: 20108992 Review.
Amlodipine/atorvastatin (Caduet) is a single-tablet, fixed-dose combination of the dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase inhibitor atorvastatin. The bioavailability of amlodipine and atorvastat …
Amlodipine/atorvastatin (Caduet) is a single-tablet, fixed-dose combination of the dihydropyridine calcium channel anta …
Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations.
Shah DA, Bhatt KK, Mehta RS, Baldania SL, Gandhi TR. Shah DA, et al. Indian J Pharm Sci. 2008 Nov;70(6):754-60. doi: 10.4103/0250-474X.49117. Indian J Pharm Sci. 2008. PMID: 21369436 Free PMC article.
The calibration curves were linear in the concentration range of 0.08-20 mug/ml for atorvastatin calcium and 0.1-20 mug/ml for amlodipine besylate. Atorvastatin calcium and amlodipine besylate stock solutions were subjected to acid and al …
The calibration curves were linear in the concentration range of 0.08-20 mug/ml for atorvastatin calcium and 0.1-20 mug/ml for …
290 results